Axium Healthcare Pharmacy

What Axium Healthcare Pharmacy does

Axium Healthcare Pharmacy is a privately held specialty pharmacy that operates exclusively in Puerto Rico, serving patients with chronic and complex conditions across eight therapeutic categories: dermatology, gastroenterology, growth hormone, multiple sclerosis, oncology, pulmonary, rare disease, and rheumatology. Founded in 2007, the company has grown from six associates to 251-500 employees and operates from a 30,000 sq. ft. state-of-the-art facility in San Juan. It dispenses 245+ limited distribution drugs in oral, infused, and injectable formulations and has secured exclusive Puerto Rico specialty pharmacy agreements with BioMarin, Alnylam, ImmunoGen, Karyopharm, and Rigel, along with authorized status with Mitsubishi Tanabe Pharma America.

The company's technology platform centers on a proprietary Hub Care Model that coordinates care among patients, prescribers, pharma partners, and payers, supplemented by a non-adherence prediction capability used to drive proactive patient outreach. Revenue is generated on a transaction-fee basis through pharmacy dispensing services reimbursed by commercial insurance, Vital/Medicaid, and Medicare Advantage plans, with patients responsible for deductibles and copays that are partially offset by manufacturer and foundation assistance programs. Go-to-market is sales-led, anchored on prescriber relationships and direct patient referrals, with medications delivered to homes, physician offices, or infusion centers across the island within 48 hours, supplemented by in-person pickup at the San Juan location.

Axium holds dual URAC (v4.0, 2016) and ACHC (2010) specialty pharmacy accreditations and is the only pharmacy in Puerto Rico with ACHC's Rare Disease and Orphan Drugs certification. The company is a corporate member of the National Association of Specialty Pharmacy (NASP). Management includes Milton Latoni (VP, Sales & Business Development), Nicole Quiles (Pharmacy Director), and Andres Martinez (Sales Director). The company is independently owned with no disclosed parent company, institutional investor, or public listing.

Name

Axium Healthcare Pharmacy

Legal name

Axium Healthcare

Website

https://axiumpr.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

251–500 employees

Short description

Axium Healthcare Pharmacy is a dually accredited (URAC and ACHC) specialty pharmacy operating exclusively in Puerto Rico, dispensing 245+ limited distribution drugs across eight therapeutic categories to patients with chronic and complex conditions under exclusive manufacturer partnerships.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Services

NAICS

Pharmacies and Drug Retailers (456110)

SIC

Retail-Drug Stores And Proprietary Stores (5912), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC)

akta.pro secondary industries

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

Keywords

• Specialty pharmacy services
• Limited distribution drugs
• Rare disease therapies
• Oncology pharmacy dispensing
• Patient journey management

Headquarters

HQ city

Lake Mary

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Infrastructure, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmacy Dispensing Services: Revenue generated from dispensing specialty medications to patients with chronic conditions. The pharmacy accepts insurance payments from commercial plans, government health plans (Vital/Medicaid), and Medicare Advantage. Patients may have out-of-pocket costs including deductibles and copays.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Axium Healthcare Pharmacy is a dually accredited (URAC and ACHC) specialty pharmacy in Puerto Rico that dispenses limited distribution specialty medications across eight therapy categories (dermatology, gastroenterology, growth hormone, multiple sclerosis, oncology, pulmonary, rare disease, and rheumatology). The pharmacy provides end-to-end patient care coordination including prescription intake, insurance verification, prior authorization, financial assistance, clinical support, and medication delivery, operating as an exclusive specialty pharmacy partner for numerous pharmaceutical manufacturers in the Puerto Rico market.

Product overview

Axium Healthcare Puerto Rico is a dually accredited specialty pharmacy (URAC and ACHC) offering comprehensive therapy-management programs and injectable/oral pharmaceutical treatments across eight specialty categories: Dermatology, Gastroenterology, Growth Hormone, Multiple Sclerosis, Oncology, Pulmonary, Rare Disease, and Rheumatology. The pharmacy operates a limited distribution drug portfolio with 245+ medications including oral, infused, and injectable formulations. Services include patient journey management from prescription intake through ongoing care, medication delivery across Puerto Rico, financial assistance programs, prior authorization coordination, clinical support, and patient advocacy. The company has partnerships with multiple pharmaceutical manufacturers for exclusive specialty pharmacy dispensing of their FDA-approved products in Puerto Rico.

Differentiator

Problem solved

Functional benefit

Products and services

• Dermatology Specialty Medications

Named customers6 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Six partnerships are on record, tiered core.

• BioMarin PharmaceuticalcoreStrategic or Co-development Partner · 10 April 2023BioMarin selected Axium Healthcare as their exclusive Specialty Pharmacy for the Puerto Rico market to dispense VOXZOGO for treatment of adult patients with uncontrolled levels of phenylketonuria, and PALYNZIQ for treatment that helps increase linear growth in children with achondroplasia.
• Alnylam PharmaceuticalscoreStrategic or Co-development Partner · 29 March 2023Alnylam selected Axium Healthcare as their exclusive Specialty Pharmacy for the Puerto Rico market to dispense all FDA-approved products (ONPATTRO, AMVUTTRA, GIVLAARI, and OXLUMO) in the Rare Disease therapy category.
• ImmunoGencoreStrategic or Co-development Partner · 1 March 2023ImmunoGen selected Axium Healthcare as their exclusive Specialty Pharmacy for the Puerto Rico market to dispense ELAHERE for treatment of adults with folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
• Mitsubishi Tanabe Pharma AmericacoreStrategic or Co-development Partner · 24 February 2023Mitsubishi Tanabe Pharma America selected Axium Healthcare as an authorized Specialty Pharmacy for the Puerto Rico market to dispense RADICAVA ORS for treatment of amyotrophic lateral sclerosis (ALS).
• Karyopharm TherapeuticscoreStrategic or Co-development Partner · 13 January 2023Karyopharm Therapeutics selected Axium Healthcare as their exclusive Specialty Pharmacy for the Puerto Rico market to dispense XPOVIO for treatment of multiple myeloma and relapsed or refractory disease in adults.
• Rigel PharmaceuticalscoreStrategic or Co-development Partner · 1 January 2023Rigel Pharmaceuticals selected Axium Healthcare as their exclusive Specialty Pharmacy for the Puerto Rico market to dispense REZLIDHIA for treatment of relapsed or refractory acute myeloid leukemia (AML) in adults.

Scale indicators5 records

Recent moves9 records

Expansion highlights4 records

Direct peers

• Amber Specialty Pharmacy (Hy-Vee): Independent specialty pharmacy serving patients with chronic, complex, and rare diseases including oncology, hepatitis C, and autoimmune conditions. Comparable to Axium's hub-driven care model, multi-specialty therapy portfolio, and limited distribution drug dispensing.
• PANTHERx Rare Pharmacy: US specialty pharmacy focused exclusively on rare disease and orphan drugs with hub services and limited distribution partnerships. Comparable to Axium's rare disease focus, ACHC rare-disease certification, and limited distribution model, though operating at much larger national scale.
• Diplomat Pharmacy (former, now Optum/OptumRx): Was once the largest independent US specialty pharmacy serving chronic and complex conditions including oncology, multiple sclerosis, and rare diseases. Comparable to Axium's specialty therapy breadth and limited distribution focus; subsequently acquired by Optum, illustrating the consolidation path for similar specialty pharmacies.
• BioPlus Specialty Pharmacy Services: Specialty pharmacy offering limited distribution drugs across multiple therapy areas with hub services and patient management. Comparable to Axium's hub care model and multi-specialty therapy portfolio; now operating as part of a larger pharmacy services platform.
• Onco360 Oncology Pharmacy: Independent specialty pharmacy focused on oncology and limited distribution cancer therapies. Comparable to Axium's oncology specialty category and exclusive pharma partnerships (e.g., Karyopharm, ImmunoGen, Rigel), though serving the broader US market.

Broad incumbents

• Walgreens Specialty Pharmacy: Specialty pharmacy arm of Walgreens Boots Alliance dispensing limited distribution and complex therapies through a national retail-adjacent network. Comparable in specialty dispensing scope, with broader scale and retail footprint advantages.
• CVS Specialty (CVS Health): Specialty pharmacy division of CVS Health offering nationwide specialty drug dispensing and care management. Comparable in therapy area breadth and hub services, with the additional competitive advantage of PBM/retail pharmacy integration.
• Accredo (Express Scripts/Evernorth): One of the largest US specialty pharmacies, owned by Evernorth/Express Scripts, offering comprehensive specialty drug dispensing across all therapy areas. Comparable in specialty pharmacy scope and limited distribution capabilities, but at vastly larger national scale with vertically integrated PBM ownership.
• US Bioservices (Cencora/AmerisourceBergen): Specialty pharmacy and distribution services business of Cencora (formerly AmerisourceBergen), offering limited distribution drug fulfillment and patient support. Comparable to Axium's specialty pharmacy and distribution functions within a much larger pharmaceutical services ecosystem.

Regional players

• CareMed Specialty Pharmacy: Specialty pharmacy serving patients with chronic complex conditions including oncology, multiple sclerosis, and rare diseases with patient management and adherence programs. Comparable to Axium's care coordination and therapy management approach, though operating in different US geographies.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/axiumpr
• LinkedInlinkedin.com/company/axium-healthcare

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Axium Healthcare Pharmacy